SSE/EFI Working Paper Series in Economics and Finance
Willingness to Pay for Hormone Replacement Therapy
() and Per-Olov Johansson
Abstract: This study addresses the question of willingness to pay
(WTP) for hormone replacement therapy (HRT) in order to alleviate
menopayusal symptoms. A utility model is specified where the individual
obtains utility from consumption of goods and health. The purchase of a
treatment is represented as a shift in the health production function
during the treatment period. The mean WTP for the HRT is estimated using a
parametric and a non-parametric method. The mean WTP based on these two
methods is similar in both cases and amounts to about SEK 40,000 per year.
Further, it is shown that the mean WTP is above the mean treatment costs of
HRT. Finally, the implied WTP per gained quality adjusted life year is
estimated at about SEK 120,000 and SEK 160,000 based on the rating scale
(RS) and time trade-off (TTO) methods, respectively.
Keywords: Hormone replacement therapy; menopausal symptoms; willingness to pay.; (follow links to similar papers)
JEL-Codes: D61; D91; I10; I12; (follow links to similar papers)
27 pages, December 18, 1997
Before downloading any of the electronic versions below
you should read our statement on
for viewing Postscript files and the
Acrobat Reader for viewing and printing pdf files.
Full text versions of the paper:
hastef0214.pdf.zip (zipped) (73kB)
hastef0214.ps.zip PKZipped PostScript (94kB)
hastef0214.ps PostScript file (677kB)
- This paper is forthcoming as:
Zethraeus, Niklas and Per-Olov Johansson, 'Willingness to Pay for Hormone Replacement Therapy', Journal of Health Economics.
Questions (including download problems) about the papers in this series should be directed to Helena Lundin ()
Report other problems with accessing this service to Sune Karlsson ()
or Helena Lundin ().
Design by Joachim Ekebom